Catalyst News and Research

RSS

Researchers receive NIH grant to study key proteins linked to cancer and diabetes

Researchers from the Polytechnic Institute of New York University and NYU have received a grant from the National Institutes of Health (NIH) to further a novel approach to understanding the genetic underpinnings of diseases including cancer and diabetes.

21 Jun 2013

Air-pollution-removal technology in "self-cleaning" paints may cause more problems than they solve

Research by Indiana University environmental scientists shows that air-pollution-removal technology used in "self-cleaning" paints and building surfaces may actually cause more problems than they solve.

13 Jun 2013

Smartphone users can now diagnose diabetes or lung cancer quickly and effectively by simply breathing

Today's technological innovation enables smartphone users to diagnose serious diseases such as diabetes or lung cancer quickly and effectively by simply breathing into a small gadget, a nanofiber breathing sensor, mounted on the phones.

12 Jun 2013

RTI Biologics intents to acquire privately held Pioneer Surgical Technology

RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, announced today its intent to acquire privately held Pioneer Surgical Technology, headquartered in Marquette, Mich.

12 Jun 2013

Growth factor helps hair follicles regenerate during wound healing process, say researchers

Researchers in the Perelman School of Medicine at the University of Pennsylvania have determined the role of a key growth factor, found in skin cells of limited quantities in humans, which helps hair follicles form and regenerate during the wound healing process.

3 Jun 2013

Researchers develop RNA aptamers that inhibit HCV replication

Treatments against hepatitis C virus have only been partially successful. A major problem is that antivirals generate drug resistance. Now Seong-Wook Lee of Dankook University, Yongin, Republic of Korea and his collaborators have developed agents that bind to the business end of a critical protein, disabling it so successfully that no resistance has arisen.

3 Jun 2013

Atopix awarded grant to pursue development of OC459 for atopic dermatitis

Atopix Therapeutics Ltd, a biopharmaceutical company developing a novel class of anti-allergic medicines, has been awarded a £1.7 million grant from the UK Biomedical Catalyst fund to pursue development of OC459 in the treatment of moderate-to-severe atopic dermatitis (a form of eczema).

29 May 2013

Researchers pinpoint catalytic trigger for onset of Alzheimer's disease

Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease - when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons in the brain.

21 May 2013

Deficit projections likely to reduce 'grand bargain' pressure

The Congressional Budget Office reports the deficit is shrinking at a faster-than-expected rate this year. Medicare and Medicaid outlays are smaller than anticipated, and health care cost increases appear to have slowed. The numbers are expected to lessen the momentum to cut spending on Medicare and other entitlement programs.

16 May 2013

Community Catalyst study shows dental therapists expand access to people in remote areas

Lack of access to dental care in the United States has reached epic proportions. Dental disease is the number one chronic illness affecting children - more common than asthma. The Institute of Medicine clearly states that the current dental delivery system doesn't work for a third of the people in the U.S.

16 May 2013

First Edition: May 15, 2013

Today's headlines include reports about how the latest Congressional Budget Office projections could further stall efforts to reach a grand bargain that includes changes to Medicare and other entitlement programs.

15 May 2013

New report analyzes economic viability of practicing midlevel dental providers in US

A new report assessing the economic viability of services provided by practicing midlevel dental providers in the U.S. shows that they are expanding preventive dental care to people who need it most: children and those who can't afford care.

15 May 2013

TriStar Wellness Solutions completes acquisition of HemCon Medical Technologies

TriStar Wellness Solutions, Inc., a health and wellness company that targets opportunities in the self-care and professional marketplace, has acquired HemCon Medical Technologies Inc., a Portland, Oregon-based leading researcher and manufacturer of products for bleeding and wound management.

13 May 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Kinase inhibitors are molecules that block the activity of kinases. Kinases are a specific class of enzymes. They are extremely important in signal transduction processes in the human body meaning that they actually regulate most of the physiological processes that take place in the body.

7 May 2013

Researchers evaluate lung-related health impacts associated with engineered nanomaterials

For the first time, researchers from institutions around the country have conducted an identical series of toxicology tests evaluating lung-related health impacts associated with widely used engineered nanomaterials (ENMs).

7 May 2013

MCCIR scientists use video imaging to investigate effectiveness of rituximab in killing cancerous B cells

Scientists from the Manchester Collaborative Centre for Inflammation Research have discovered why a particular cancer drug is so effective at killing cells.

From The University of Manchester 25 Apr 2013

University of Utah researchers develop novel technique to identify RNA cytosine methyltransferases

Researchers from Huntsman Cancer Institute at the University of Utah have developed a novel and powerful technique to identify the targets for a group of enzymes called RNA cytosine methyltransferases in human RNA.

23 Apr 2013

Study identifies potential drug targets that interfere with cancer metabolism

A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer.

22 Apr 2013

Key points about the Global Fund from Executive Director Dybul

Writing in the International Health Policies blog, Rachel Hammonds of the Institute of Tropical Medicine in Belgium, writes about a "panel discussion organized by several [members of the European Parliament], the Stop Aids Alliance and others at the European Parliament on 8 April" that discussed the Global Fund to Fight AIDS, Tuberculosis and Malaria.

19 Apr 2013

Flunisyn Phase 2a trial data shows positive results in elderly population

Following the widely publicised US Centers for Disease Control and Prevention report in February that the current season's flu vaccine is only 9% effective in the over-65 population, Immune Targeting Systems Limited, today announces positive data from a Phase 2a trial with the Company's lead pan-strain influenza A T-cell vaccine, Flunisyn, in the elderly population.

17 Apr 2013